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Summary
We employed a genetic approach to determine whether deficiency of 1,25-dihydroxyvitamin D [1, 25(OH) 2 ) gene, the VDR gene, and both genes, were exposed to either: a high calcium intake, which maintained fertility but left mice hypocalcemic; this intake plus thrice weekly injections of 1,25(OH) 2 interacts with a putative membrane receptor, mediating the opening of calcium and chloride voltage-gated channels and activating MAP kinase (15) .
We (16) and others (17) (23). Rescue of this phenotype has been successfully accomplished with a high-calcium, highphosphorus, high-lactose diet administered for at least 1 month after weaning (22, 24) .
Consequently, it has been postulated that the major action of the VDR in skeletal growth, maturation and remodeling is its role in intestinal calcium absorption (25 RT-PCR-RNA was isolated from mouse kidney and long bones, using Trizol reagent Histology-Thyroparathyroidal tissue, femurs and tibiae were removed and fixed in PLP fixative (2% paraformaldehyde containing 0.075M lysine and 0.01M sodium periodate) overnight at 4°C
and processed histologically as previously described (28) . The proximal ends of the tibiae were decalcified in ethylene-diamine tetra-acetic acid (EDTA) glycerol solution for 5-7 days at 4°C.
Decalcified tibiae and other tissues were dehydrated and embedded in paraffin after which 5 µm sections were cut on a rotary microtome. The sections were stained with hematoxylin and eosin (H&E) or histochemically for collagen, alkaline phosphatase activity (ALP), or tartrate resistant acid phosphatase (TRAP) activity as described below. Alternatively, undecalcified tibiae were embedded in LR White acrylic resin (London Resin Company Ltd., London, UK) and 1-µm sections were cut on an ultramicrotome. These sections were stained for mineral with the von Kossa staining procedure and counterstained with toluidine blue.
Immunohistochemical staining for aggrecan and RANKL -The cartilage matrix protein, aggrecan, and the transcription factor, RANKL, were determined by immunohistochemistry as described previously (28) . Briefly, rabbit antiserum to bovine aggrecan (R130, courtesy of Dr.
A.R. Poole, Shriners Hospital, Montreal, Canada) or affinity purified goat polyclonal antibody raised against a peptide mapping at the carboxy terminus of RANKL (C-20, Santa Cruz Biotechnology Inc., Santa Cruz, California, USA) were applied to de-waxed paraffin sections overnight at room temperature. As a negative control, the pre-immune serum was substituted for the primary antibody. After washing with high salt buffer (50 mM Tris-HCl, 2.5% NaCl, 0.05% Tween 20, pH 7.6) for 10 min at room temperature followed by two 10-min washes with PBS, the sections were incubated with secondary antibody (biotinylated goat anti-rabbit IgG or The sections were then washed with distilled water, counterstained with methyl green, and mounted with Kaiser's glycerol jelly.
Histochemical staining for collagen, alkaline phosphatase (ALP) and tartrate resistant acid
phosphatase (TRAP) -Total collagen was detected in paraffin sections using a modified method of Lopez-De Leon and Rojkind (29) . De-waxed sections were exposed to 1% sirius red in saturated picric acid for 1 h. After washing with distilled water, the sections were counterstained with haematoxylin, and mounted with Biomount medium.
Enzyme histochemistry for ALP activity was performed as previously described (30, 31) .
Briefly, following preincubation overnight in 1% magnesium chloride in 100 mm tris-maleate buffer (pH 9.2), de-waxed sections were incubated for 2 hours at room temperature in a 100 mM tris-maleate buffer containing naphthol AS-MX phosphate (0.2mg/ml, Sigma) dissolved in ethylene glycol monomethyl ether (Sigma) as substrate, and fast red TR (0.4mg/ml, Sigma) as a stain for the reaction product. After washing with distilled water, the sections were counterstained with Vector methyl green nuclear counterstain (Vector laboratories), and mounted with Kaiser's glycerol jelly.
Enzyme histochemistry for TRAP was performed using a modification of a previously described protocol (32) . De-waxed sections were pre-incubated for 20 minutes in buffer containing 50 mM sodium acetate and 40 mM sodium tartrate at pH 5.0. Sections were then incubated for 15 minutes at room temperature in the same buffer containing 2.5 mg/ml naphthol 11 AS-MX phosphate (Sigma) in dimethylformamide as substrate, and 0.5mg/ml fast garnet GBC (Sigma) as a color indicator for the reaction product. After washing with distilled water the sections were counterstained with methyl green and mounted in Kaiser's glycerol jelly.
Double calcein labeling-Double calcein labeling was performed by intra-peritoneal injection of mice with 10 µg calcein/g body weight (C-0875, Sigma) at 10 days and 3 days prior to sacrifice.
Bones were harvested and embedded in LR White acrylic resin described as above. Serial sections were cut and the freshly cut surface of each section was viewed and imaged using fluorescence microscopy. The double calcein labeled width of cortex and trabeculae was measured using Northern Eclipse image analysis software v6.0 (Empix Imaging Inc., Mississauga, ON) and the mineral apposition rate (MAR) was calculated as the interlabel width/labeling period.
Computer-assisted image analysis-After H&E staining or histochemical staining of sections from six mice of each genotype on each dietary regimen, images of fields were photographed with a Sony digital camera. Images of micrographs from single sections were digitally recorded using a rectangular template, and recordings were processed using Northern Eclipse image analysis software (28, 33) . To measure the size of the parathyroid glands, the border of the glands were traced on micrographs of H&E stained sections and traced areas of parathyroid glands were recorded automatically by Northern Eclipse image analysis software. For measuring the width of growth plates of tibiae, the distances between the proximal (epiphyseal) and distal (metaphyseal) sides of the growth plate were traced on micrographs of H&E stained sections and traced distances were recoded automatically by Northern Eclipse image analysis software. For determining the trabecular bone volume relative to the total volume (BV/TV) in collagen stained sections, the osteoid volume relative to the bone volume (OV/BV) in von Kossa stained sections,
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ALP positive area and intensity (summary total gray) in ALP histochemical stained sections, and the number and size of osteoclasts in TRAP histochemical stained sections, thresholds were set using green and red channels. The thresholds were determined as described previously (28) . The trabecular volume was measured in the metaphyseal region from 0.5 mm below the distal (metaphyseal) side of the growth plate to 1.5 mm towards the diaphysis and ALP and TRAP parameters were measured in the fields of metaphyseal regions.
Bone marrow cell cultures -Primary bone marrow cell cultures were performed as previously Expression of 1α(OH)ase and 24(OH)ase genes-The 1α(OH)ase gene was expressed at higher levels in the VDR -/-mice than in wild-type mice when animals received a high calcium intake (Fig. 1b, left panel) ; this was not reduced by administering exogenous 1,25(OH) 2 D 3 to these animals ( Fig. 1b , right panel) but was reduced by eliminating hypocalcemia with the rescue diet (Fig. 1b, middle panel) .
Expression of the 24(OH)ase gene was reduced in all mutant mice on the high calcium diet (Fig. 1b, upper (Fig. 1b, lower panel) . On the rescue diet, 24(OH)ase gene expression was restored to normal or near normal (Fig. 1b, middle panel) . On the high calcium intake, all mutant animals were hypocalcemic (Fig. 1d) All the hypocalcemic mutant mice had markedly elevated serum PTH concentrations on the high calcium intake ( Fig.1e ) and these animals were also hypophosphatemic (Fig.1f) . Serum alkaline phosphatase levels, most likely reflecting osteoblast stimulation, paralleled the PTH levels ( Fig. 1g) . In mutant animals on the rescue diet, serum PTH concentrations as well as serum phosphorus and alkaline phosphatase , all returned to the wild-type range (Fig. 1e-g ). (Fig. 1e-g ).
Biochemistry-On
Parathyroid Gland Size in Wild-Type and Mutant Mice-Although the parathyroid glands in the VDR -/-mice were enlarged on the high calcium intake they were even larger in the 1α(OH)ase -/-mice and the 1α(OH)ase -/-VDR -/-mice ( Fig. 2a and 2d ). On the rescue diet, parathyroid gland size decreased into the normal range in the normocalcemic VDR -/-mice but still remained significantly enlarged in the two normocalcemic but 1,25(OH) 2 D deficient models i.e., the 1α(OH)ase -/-mice and the 1α(OH)ase -/-VDR -/-mice ( Fig. 2b and 2d ). After 1,25(OH) 2 D 3 treatment parathyroid gland size normalized in the 1α(OH)ase -/-animals but not in the two VDR deficient models i.e., the VDR -/-and the double mutant that remained hypocalcemic.
Skeletal Alterations-On the high calcium intake femoral size was significantly reduced in all hypocalcemic mutant models reflecting decreased long bone growth (Fig. 3a) . On the rescue diet, femoral size of all 3 mutant models remained slightly decreased but approached that of the wildtype (Fig. 3b) . Exogenous 1,25(OH) 2 D 3 treatment only improved femoral growth of the 1α(OH)ase -/-mice and not that of the VDR -/-or the double mutants (Fig. 3c) .
The cartilaginous growth plates were enlarged and distorted in all three mutant models on the high calcium intake, but these alterations were most pronounced in the 1α(OH)ase -/-mice and the 1α(OH)ase Fig. 4c and 4d ).
Trabecular bone volume (BV/TV) was increased in all three hypocalcemic mutant models on a high calcium intake ( Fig. 5a and 5d ) but after 4 months on a rescue diet, trabecular bone volume was reduced in all three mutants below the levels in wild-type animals ( Fig. 5b and   5d ). In contrast, treatment with 1,25(OH) 2 D 3 normalized trabecular bone volumes in the 1α(OH)ase -/-mice but not in the other two models ( Fig. 5c and 5d ).
In the hypocalcemic mice on the high calcium intake, osteoid volume reflecting unmineralized bone matrix was increased in all mutant animals in both trabecular and cortical bone ( Fig. 6a and b) . When hypocalcemia was eliminated by the rescue diet, osteoid volume was reduced to that of wild-type in all mutants. In contrast, exogenous 1,25(OH) 2 D 3 treatment normalized osteoid only in the 1α(OH)ase -/-mice ( Fig. 6a and b Fig. 6c and d) .
Osteoblast levels were significantly elevated in all 3 mutants with secondary hyperparathyroidism (Fig. 7a and d) on the high calcium intake and Cbfa I mRNA and protein expression in bone were also increased ( Fig. 7e and f) . Osteoblasts were significantly reduced in the mutants on the rescue diet, to levels below those in wild-type mice ( Fig. 7b and d) and Cbfa I mRNA or protein were also reduced ( Fig. 7e and f) . After exogenous 1,25(OH) 2 D 3 treatment, only the 1α(OH)ase -/-mice normalized their osteoblast levels whereas these remained elevated in the VDR -/-and the double mutants ( Fig. 7c and d) .
To determine the cause of the reduced osteoblasts in the mutants on the rescue diet primary bone marrow cultures were examined for the capacity to formed osteogenic colonies from marrow progenitors. Reduced bone forming colonies were observed in the marrow of all 3 mutants on the rescue diet compared with wild-type controls (Fig. 8) .
TRAP-positive osteoclast numbers were not significantly different from levels in wildtype animals in any of the mutants exposed to any of the dietary manipulations (Fig. 9) .
However, the average size of the TRAP-positive osteoclasts was reduced in all 3 mutants on the high calcium intake. On the rescue diet, TRAP-positive osteoclast size was no different in the mutant mice than in wild-type mice. After 1,25(OH) 2 D 3 treatment, however, only the 1α(OH)ase -/-mice normalized and average osteoclast size remained below wild-type in the VDR -/-and double mutants ( Fig. 9c and d) .
Expression of RANKL mRNA was diminished in bone of the mutants compared to wildtype bone, when the animals were on a high calcium intake (Fig. 10a) . RANKL protein in osteoblastic cells was also found to be low in all three mutants on the high calcium intake ( 
DISCUSSION
We have analyzed mouse mutants which harbor deletions of the genes encoding the 1α(OH)ase, the VDR or both genes and subjected them to three different nutritional regimens.
The analysis of the double mutants allowed us to assess which phenotypic differences seen in these animals compared to the VDR -/-mice might be due to the elevated endogenous Bone volume and osteoblast numbers were increased in the mutant animals with secondary hyperparathyroidism as has been previously reported in studies with the 1α(OH)ase -/- (16, 17) and the VDR -/-models (20, 21) . These increases most likely reflect the well characterized "anabolic" activity of PTH (42) . Consistent with this observation, increases were observed in the transcription factor Cbfa I/Runx2, which is known to be essential for osteoblastic differentiation during embryogenesis and is also required for the anabolic effect of PTH in postnatal animals (43) . The increased bone volume was however associated with increased osteoid volume in the animals with secondary hyperparathyroidism. In those animals who received a high calcium intake, serum calcium levels, although decreased, were higher than we and others have previously reported in mutant mice fed a normal calcium intake (16, 17, 20, 21) . Osteoid volumes 22 were therefore lower than in previous reports. In addition mineral apposition could be detected and was, in fact, elevated in the mice with secondary hyperparathyroidism. The mineral apposition rate fell as PTH levels fell reflecting the reduced bone formation. Unmineralized osteoid was no greater than in wild-type mice when hypocalcemia and hypophosphatemia were eliminated i.e., in 1,25(OH) 2 D 3 -treated 1α(OH)ase -/-mice, but also in all mutants on the rescue diet. Consequently once extracellular calcium and phosphorus levels are normalized mineralization of osteoid does not appear to require the 1,25(OH) 2 D/VDR system.
Despite greatly increased PTH levels, osteoclast numbers in these mutants with deficiency of the 1,25(OH) 2 D/VDR system were not significantly increased above levels observed in normocalcemic vitamin D-replete wild-type controls whose PTH levels were normal.
Bone turnover in the mutant animals was therefore uncoupled and osteoclast numbers in the mutants could be considered inappropriately low. We did find, in the present studies, that average osteoclast size was decreased in the mutants with secondary hyperparathyroidism on the high calcium diet and in the 1,25(OH) 2 D 3 treated VDR -/-and double mutants. Furthermore, levels of RANKL, the transcription factor stimulated by 1,25(OH) 2 D 3 which is required for the normal differentiation and maintenance of osteoclasts (44) were also decreased in the mutants.
Consequently, the 1,25(OH) 2 D/VDR system appears necessary for maximal PTH-induced osteoclast production and the increase in bone volume appeared to reflect enhanced osteoblastic activity due to PTH that was dissociated from an increase in bone resorption.
The increase in the thickness of the cartilaginous growth plate in the mutants may also have been contributed to by impaired growth plate remodeling i.e., impaired resorption of hypertrophic chondrocytes by chondroclasts/osteoclasts at the chondro-osseous junction. This has been previously noted in VDR -/-mutants (26) . It has been reported that in co-cultures in vitro using wild-type spleen cells but osteoblasts from VDR -/-mice, 1,25(OH) 2 D 3 was unable to stimulate osteoclast production whereas PTH and other bone resorbing agents could (45).
Consequently the "normal level" of osteoclasts seen in our in vivo models in the absence of the 1,25(OH) 2 D/VDR system may have reflected the action of PTH and other local bone resorbers.
The more exuberant osteoclastic response generally expected with sustained increases in PTH of the magnitude seen in our mutants (42) 
